Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poliovirus Type 1 Mahoney Strain Capsid Proteins (N/A)
- Target
- N/A
- Molecular classification
- Viral structural protein
01
Overview
The capsid proteins of Poliovirus Type 1 Mahoney strain (VP1, VP2, VP3, VP4) form the outer protein shell (capsid) of the virus, which is responsible for host cell attachment, entry, and antigenicity. These proteins are crucial for the virus's ability to infect cells and cause poliomyelitis. The Mahoney strain is a reference strain for understanding poliovirus structure, function, and pathogenesis, and for the development of inactivated polio vaccines. Mutations in these proteins, particularly VP1, can affect virulence, host range, and antigenicity.
- Other names
- Poliovirus Type 1 Mahoney capsidVP1VP2VP3VP4
02
Mechanism of action
Vaccines induce neutralizing antibodies against capsid proteins, preventing viral attachment and entry.
03
Biological functions
Viral capsid formationHost cell attachmentViral entryAntigenicityGenome packaging
04
Disease associations
PoliomyelitisViral infection
05
Safety considerations
Vaccine-derived poliovirus (VDPV) reversion to virulence in oral polio vaccine (OPV)Potential for immune escape due to capsid mutations
06
Interacting drugs
Poliovirus vaccines (Inactivated)
1 more in the full profile.
Beyond the preview
Go deeper on Poliovirus Type 1 Mahoney Strain Capsid Proteins (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Poliovirus Type 1 Mahoney Strain Capsid Proteins (N/A).